GlassScriptPhysician profile
Katherine Mistretta
NPI 1326543968
$40,990.78
in general payments reported to CMS, 2019-2025
10 companies · $22K in 2025
The $22K reported for 2025 was more than what 83% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $882 · 2024: $18K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $7,436 · Food and Beverage: $5,281 · Grant: $4,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,994.48 |
| Travel and Lodging | $7,436.01 |
| Food and Beverage | $5,281.32 |
| Grant | $4,278.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $23,240.35 | 2024-2025 | Actis, Velys, Reclaim |
| Depuy Synthes Products, INC. | $6,124.00 | 2025 | Velys |
| Zimmer Biomet Holdings, INC. | $5,164.14 | 2023-2025 | Persona, G7, Avenir |
| Smith+Nephew, INC. | $4,958.39 | 2024 | Journey II, Real Intelligence, Or3o Dual Mobility |
| Stryker Corporation | $762.14 | 2023-2024 | Mako, Stryker, Ezout |
| Depuy Synthes Sales INC. | $394.82 | 2023-2025 | Attune |
| Medacta USA, INC. | $194.46 | 2023-2024 | Gmk Sphere |
| Think Surgical, INC. | $111.13 | 2024 | |
| Globus Medical, INC. | $26.42 | 2023 | Ellipse/Addition C |
| Kci USA, INC. | $14.93 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mistretta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.